Does Rallies show Form 4 insider transactions for ZURA?

Yes. Rallies tracks ZURA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ZURA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ZURA. It does not provide personalized investment advice.

ZURA (Zura Bio Limited Class A Ordinary Shares) Stock Analysis - Insider Trades

Zura Bio Limited Class A Ordinary Shares (ZURA) is a publicly traded Healthcare sector company. As of May 21, 2026, ZURA trades at $4.10 with a market cap of $390.91M and a P/E ratio of -3.86. ZURA moved +2.38% today. Year to date, ZURA is -14.90%; over the trailing twelve months it is +281.78%. Its 52-week range spans $0.97 to $7.44. Analyst consensus is strong buy with an average price target of $16.40. Rallies surfaces ZURA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ZURA stock inside the company?

Recent ZURA insider activity includes AI Biotechnology LLC bought 2.00M, Thiara Parvinder sold 1.00M, Thiara Parvinder sold 3.80M, and Sidhu Someit sold 51.73K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ZURA Key Metrics

Key financial metrics for ZURA
Metric	Value
Price	$4.10
Market Cap	$390.91M
P/E Ratio	-3.86
EPS	$-1.06
Dividend Yield	0.00%
52-Week High	$7.44
52-Week Low	$0.97
Volume	2.42K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-68.65M
Gross Margin	0.00%

Recent ZURA Insider Trades

AI Biotechnology LLC bought 2.00M (~$12.50M) on Feb 26, 2026.
Thiara Parvinder sold 1.00M (~$2.73M) on Nov 25, 2024.
Thiara Parvinder sold 3.80M (~$10.26M) on Sep 11, 2024.
Sidhu Someit sold 51.73K (~$200.19K) on Sep 4, 2024.

Latest ZURA News

Zura Bio Appoints Eisner and Nirula to Board Effective Feb. 21, 2026 — Feb 23, 2026
Zura Bio Expands HS Trial to 225 Patients, Sets Phase 2 Readouts in Q4 2026 and 1H 2027 — Feb 16, 2026

ZURA Analyst Consensus

5 analysts cover ZURA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.40.

Common questions about ZURA

Who is trading ZURA stock inside the company?: Recent ZURA insider activity includes AI Biotechnology LLC bought 2.00M, Thiara Parvinder sold 1.00M, Thiara Parvinder sold 3.80M, and Sidhu Someit sold 51.73K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ZURA?: Yes. Rallies tracks ZURA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ZURA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ZURA. It does not provide personalized investment advice.